#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	4236	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2359	366.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1535	1535	C	490	C,G,A	340,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7546	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4177	369.0	0	.	n	.	0	T695C	SNP	695	695	T	1439	1439	C	633	C,T	420,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7546	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4177	369.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	2382	2382	G	408	G	301	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7546	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4177	369.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2715	2715	C	428	C	316	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7546	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4177	369.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2789	2789	A	448	A	325	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7546	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4177	369.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3341	3341	C	495	C	356	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	340	folP	855	855	100.0	folP.l15.c4.ctg.1	1905	39.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1274	1276	AGC	67;68;69	A;G;C	50;51;53	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	988	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3674	54.8	1	SNP	p	S91F	1	.	.	271	273	TTC	825	827	TTC	58;58;58	T;T;C	41;41;41	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	988	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3674	54.8	1	SNP	p	D95G	1	.	.	283	285	GGC	837	839	GGC	68;71;71	G;G;C	48;50;50	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	988	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3674	54.8	1	SNP	p	G95N	0	.	.	283	285	GGC	837	839	GGC	68;71;71	G;G;C	48;50;50	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	210	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1209	36.4	1	SNP	p	G45D	0	.	.	133	135	GGC	469	471	GGC	55;55;55	G;G;C	40;40;40	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	178	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1230	27.0	0	.	n	.	0	A197.	DEL	197	197	A	783	783	A	65	A	45	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	882	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3303	56.9	1	SNP	p	D86N	0	.	.	256	258	GAC	736	738	GAC	87;87;91	G;A;C	55;53;60	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	882	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3303	56.9	1	SNP	p	R87I	0	.	.	259	261	CGT	739	741	CGT	92;92;95	C;G;T,G	62;57;65,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	882	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3303	56.9	1	SNP	p	S87R	1	.	.	259	261	CGT	739	741	CGT	92;92;95	C;G;T,G	62;57;65,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	882	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3303	56.9	1	SNP	p	R87W	0	.	.	259	261	CGT	739	741	CGT	92;92;95	C;G;T,G	62;57;65,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	882	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3303	56.9	1	SNP	p	S88P	0	.	.	262	264	TCC	742	744	TCC	95;95;93	T;C,T;C	64;65,1;65	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	754	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3231	47.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1675	1677	GGC	32;33;33	G;G;C	23;23;21	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	770	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2575	60.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1456	1458	GCC	97;97;96	G,T;C;C	69,1;70;69	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	770	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2575	60.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1459	1461	ATG	96;97;97	A;T;G	69;70;70	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	770	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2575	60.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1471	1473	ACC	102;102;100	A,G;C;C	71,1;72;70	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	770	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2575	60.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1471	1473	ACC	102;102;100	A,G;C;C	71,1;72;70	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	770	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2575	60.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1972	1974	ACC	90;89;89	A;C,T;C	60;58,1;60	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	770	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2575	60.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2026	2028	GCG	76;74;74	G;C,G;G	53;48,1;52	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	770	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2575	60.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2026	2028	GCG	76;74;74	G;C,G;G	53;48,1;52	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	770	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2575	60.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2149	2151	GGT	60;60;59	G;G,T;T,G	46;44,2;46,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	770	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2575	60.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2158	2160	AGC	50;50;50	A;G,C;C	30;36,1;29	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	770	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2575	60.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2176	2178	CCG	45;45;45	C,G;C;G	30,2;30;32	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1074	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3358	63.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1824	1826	CCG	62;62;62	C,G;C;G,C	41,1;44;38,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	374	porA	1146	1146	99.91	porA.l6.c30.ctg.1	2056	36.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	649	649	C	31	C	24	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	58	porB1a	984	269	90.11	porB1a.l15.c4.ctg.1	1164	10.9	0	.	p	.	0	H217N	NONSYN	649	651	CAT	920	922	AAT	13;13;13	A;A;T	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	58	porB1a	984	269	90.11	porB1a.l15.c4.ctg.1	1164	10.9	0	.	p	.	0	D218N	NONSYN	652	654	GAT	923	925	AAT	13;13;11	A;A;T	10;10;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	58	porB1a	984	269	90.11	porB1a.l15.c4.ctg.1	1164	10.9	0	.	p	.	0	V226A	NONSYN	676	678	GTA	947	949	GCA	9;9;9	G;C;A	7;7;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	58	porB1a	984	269	90.11	porB1a.l15.c4.ctg.1	1164	10.9	0	.	p	.	0	.	MULTIPLE	700	702	ACT	970	972	GTA	8;8;8	G;T;A	7;7;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	58	porB1a	984	269	90.11	porB1a.l15.c4.ctg.1	1164	10.9	0	.	p	.	0	N237fs	FSHIFT	709	709	A	979	979	A	8	A	7	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	526	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1929	55.5	0	.	p	.	0	G48E	NONSYN	142	144	GGA	642	644	GAA	69;69;69	G;A;A	52;52;53	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	526	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1929	55.5	0	.	p	.	0	D292N	NONSYN	874	876	GAT	1374	1376	AAT	77;79;77	A;A;T	55;57;56	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	526	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1929	55.5	1	SNP	p	G120K	1	.	.	358	360	AAG	858	860	AAG	80;80;83	A;A;G	59;60;61	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	526	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1929	55.5	1	SNP	p	N121D	0	.	.	361	363	AAC	861	863	AAC	83;83;82	A;A;C,A	61;62;59,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	526	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1929	55.5	1	SNP	p	A121N	1	.	.	361	363	AAC	861	863	AAC	83;83;82	A;A;C,A	61;62;59,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1688	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4840	71.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	174	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1261	30.3	1	SNP	p	V57M	1	.	.	169	171	ATG	579	581	ATG	75;74;77	A;T;G	49;51;53	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
